Health Pharma Professional Research S.A. de C.V: ( Site 3301)

Mexico City, Mexico City 03100

1 studies enrolling now · 2 studies all time

What they study most

CLL, Chronic Lymphocytic Leukemia, Leukemia, Chronic Lymphocytic, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Small Lymphocytic, SLL, Small Lymphocytic Lymphoma, Small-Cell Lymphoma

Studies at this site

• A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010). — Recruiting now
• A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008) — Running, not enrolling